Manfred Ogris is a Research Group Leader at the Department of Pharmacy, Center for Drug Research. Within his research group, macromolecular carrier systems with a focus on nucleic acid delivery are developed for tumor therapy. Several projects are pursued in the field of targeted gene delivery ex vivo and after systemic administration in tumor models in vivo. Bioimaging methods based on near-infrared fluorescence and bioluminescence are applied in rodents to optimize tumor targeted nucleic acid carriers. Therapeutic approaches include not only cancer gene therapy in combination with chemotherapy or radiation, but also tumor targeted delivery of immune-stimulatory and proapoptotic RNA. Several projects are carried out within national and international research cooperation with academic groups and the pharmaceutical industry. As a lecturer, Dr. Ogris teaches pharmaceutical biology and biochemistry at the Faculty for Chemistry and Pharmacy. Dr. Ogris obtained his Ph.D. degree in biotechnology in 1999 at the University of Natural Resources and Applied Life Sciences in Vienna, Austria. Before starting as a Group Leader in Munich in 2001, he was a Postdoctoral Research Fellow at the CRC Institute for Cancer Research in Birmingham, UK, and was granted a Marie Curie Fellowship from the European Union. In 2009, Dr. Ogris obtained his habilitations (venia docendi) for pharmaceutical biology and pharmaceutical biotechnology at the Department of Pharmacy. In 2012, he was offered a full professorship for pharmaceutical sciences at the University of Vienna.
Biography Updated on 22 April 2013